Details der Publikation - Mapping Community-Engaged Implementation Strategies with Transgender Scientists, Stakeholders, and Trans-Led Community Organizations

Mapping Community-Engaged Implementation Strategies with Transgender Scientists, Stakeholders, and Trans-Led Community Organizations

Purpose of Review Pre-exposure prophylaxis (PrEP) represents one of the most effective methods of prevention for HIV, but remains inequitable, leaving many transgender and nonbinary (trans) individuals unable to benefit from this resource. Deploying community-engaged PrEP implementation strategies for trans populations will be crucial for ending the HIV epidemic. Recent Findings While most PrEP studies have progressed in addressing pertinent research questions about gender-affirming care and PrEP at the biomedical and clinical levels, research on how to best implement gender-affirming PrEP systems at the social, community, and structural levels remains outstanding. Summary The science of community-engaged implementation to build gender-affirming PrEP systems must be more fully developed. Most published PrEP studies with trans people report on outcomes rather than processes, leaving out important lessons learned about how to design, integrate, and implement PrEP in tandem with gender-affirming care. The expertise of trans scientists, stakeholders, and trans-led community organizations is essential to building gender-affirming PrEP systems..

Medienart:	E-Artikel

Erscheinungsjahr:	2023
Erschienen:	2023

Enthalten in:	Zur Gesamtaufnahme - volume:20
Enthalten in:	Current HIV AIDS reports - 20(2023), 3 vom: 04. Apr., Seite 160-169

Sprache:	Englisch

Beteiligte Personen:	Restar, Arjee [VerfasserIn] Minalga, Brian J. [VerfasserIn] Quilantang, Ma. Irene [VerfasserIn] Adamson, Tyler [VerfasserIn] Dusic, Emerson [VerfasserIn] van der Merwe, Leigh-Ann [VerfasserIn] Millet, Greg [VerfasserIn] Rosadiño, Danvic [VerfasserIn] Laguing, Tanya [VerfasserIn] Lett, Elle [VerfasserIn] Everhart, Avery [VerfasserIn] Phillips, Gregory [VerfasserIn] Janamnuaysook, Rena [VerfasserIn] Seekaew, Pich [VerfasserIn] Baker, Kellan [VerfasserIn] Ashley, Florence [VerfasserIn] Wickersham, Jeffrey [VerfasserIn] Wallace, Stephaun E. [VerfasserIn] Operario, Don [VerfasserIn] Gamarel, Kristi E. [VerfasserIn]

Links:	Volltext [kostenfrei]

BKL:	44.78$jImmunkrankheiten
Themen:	Gender-affirming care HIV prevention Implementation Nonbinary PrEP Transgender

Anmerkungen:	© This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023

doi:	10.1007/s11904-023-00656-y

funding:
Förderinstitution / Projekttitel:

PPN (Katalog-ID):	OLC2143615000

Internformat


LEADER	01000naa a22002652 4500
001	OLC2143615000
003	DE-627
005	20240118090901.0
007	cr uuu---uuuuu
008	240118s2023 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1007/s11904-023-00656-y \|2 doi
035			\|a (DE-627)OLC2143615000
035			\|a (DE-He213)s11904-023-00656-y-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
082	0	4	\|a 610 \|q VZ
084			\|a 44.78$jImmunkrankheiten \|2 bkl
100	1		\|a Restar, Arjee \|e verfasserin \|0 (orcid)0000-0003-2992-8198 \|4 aut
245	1	0	\|a Mapping Community-Engaged Implementation Strategies with Transgender Scientists, Stakeholders, and Trans-Led Community Organizations
264		1	\|c 2023
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023
520			\|a Purpose of Review Pre-exposure prophylaxis (PrEP) represents one of the most effective methods of prevention for HIV, but remains inequitable, leaving many transgender and nonbinary (trans) individuals unable to benefit from this resource. Deploying community-engaged PrEP implementation strategies for trans populations will be crucial for ending the HIV epidemic. Recent Findings While most PrEP studies have progressed in addressing pertinent research questions about gender-affirming care and PrEP at the biomedical and clinical levels, research on how to best implement gender-affirming PrEP systems at the social, community, and structural levels remains outstanding. Summary The science of community-engaged implementation to build gender-affirming PrEP systems must be more fully developed. Most published PrEP studies with trans people report on outcomes rather than processes, leaving out important lessons learned about how to design, integrate, and implement PrEP in tandem with gender-affirming care. The expertise of trans scientists, stakeholders, and trans-led community organizations is essential to building gender-affirming PrEP systems.
650		4	\|a PrEP
650		4	\|a Implementation
650		4	\|a Transgender
650		4	\|a Nonbinary
650		4	\|a Gender-affirming care
650		4	\|a HIV prevention
700	1		\|a Minalga, Brian J. \|4 aut
700	1		\|a Quilantang, Ma. Irene \|4 aut
700	1		\|a Adamson, Tyler \|4 aut
700	1		\|a Dusic, Emerson \|4 aut
700	1		\|a van der Merwe, Leigh-Ann \|4 aut
700	1		\|a Millet, Greg \|4 aut
700	1		\|a Rosadiño, Danvic \|4 aut
700	1		\|a Laguing, Tanya \|4 aut
700	1		\|a Lett, Elle \|4 aut
700	1		\|a Everhart, Avery \|4 aut
700	1		\|a Phillips, Gregory \|4 aut
700	1		\|a Janamnuaysook, Rena \|4 aut
700	1		\|a Seekaew, Pich \|4 aut
700	1		\|a Baker, Kellan \|4 aut
700	1		\|a Ashley, Florence \|4 aut
700	1		\|a Wickersham, Jeffrey \|4 aut
700	1		\|a Wallace, Stephaun E. \|4 aut
700	1		\|a Operario, Don \|4 aut
700	1		\|a Gamarel, Kristi E. \|4 aut
773	0	8	\|i Enthalten in \|t Current HIV AIDS reports \|d Springer US, 2004 \|g 20(2023), 3 vom: 04. Apr., Seite 160-169 \|h Online-Ressource \|w (DE-627)481276858 \|w (DE-600)2179699-3 \|w (DE-576)306832046 \|x 1548-3576 \|7 nnns
773	1	8	\|g volume:20 \|g year:2023 \|g number:3 \|g day:04 \|g month:04 \|g pages:160-169
856	4	0	\|u https://dx.doi.org/10.1007/s11904-023-00656-y \|z kostenfrei \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_OLC
912			\|a GBV_ILN_11
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_31
912			\|a GBV_ILN_32
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_70
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_90
912			\|a GBV_ILN_95
912			\|a GBV_ILN_100
912			\|a GBV_ILN_101
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_120
912			\|a GBV_ILN_138
912			\|a GBV_ILN_150
912			\|a GBV_ILN_151
912			\|a GBV_ILN_152
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_171
912			\|a GBV_ILN_187
912			\|a GBV_ILN_213
912			\|a GBV_ILN_224
912			\|a GBV_ILN_230
912			\|a GBV_ILN_250
912			\|a GBV_ILN_281
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_370
912			\|a GBV_ILN_602
912			\|a GBV_ILN_636
912			\|a GBV_ILN_702
912			\|a GBV_ILN_2001
912			\|a GBV_ILN_2003
912			\|a GBV_ILN_2004
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2006
912			\|a GBV_ILN_2007
912			\|a GBV_ILN_2008
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2010
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_2015
912			\|a GBV_ILN_2020
912			\|a GBV_ILN_2021
912			\|a GBV_ILN_2025
912			\|a GBV_ILN_2026
912			\|a GBV_ILN_2027
912			\|a GBV_ILN_2031
912			\|a GBV_ILN_2034
912			\|a GBV_ILN_2037
912			\|a GBV_ILN_2038
912			\|a GBV_ILN_2039
912			\|a GBV_ILN_2044
912			\|a GBV_ILN_2048
912			\|a GBV_ILN_2049
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2057
912			\|a GBV_ILN_2059
912			\|a GBV_ILN_2061
912			\|a GBV_ILN_2064
912			\|a GBV_ILN_2065
912			\|a GBV_ILN_2068
912			\|a GBV_ILN_2088
912			\|a GBV_ILN_2093
912			\|a GBV_ILN_2106
912			\|a GBV_ILN_2107
912			\|a GBV_ILN_2108
912			\|a GBV_ILN_2110
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_2112
912			\|a GBV_ILN_2113
912			\|a GBV_ILN_2118
912			\|a GBV_ILN_2129
912			\|a GBV_ILN_2143
912			\|a GBV_ILN_2144
912			\|a GBV_ILN_2147
912			\|a GBV_ILN_2148
912			\|a GBV_ILN_2152
912			\|a GBV_ILN_2153
912			\|a GBV_ILN_2188
912			\|a GBV_ILN_2190
912			\|a GBV_ILN_2232
912			\|a GBV_ILN_2336
912			\|a GBV_ILN_2446
912			\|a GBV_ILN_2470
912			\|a GBV_ILN_2474
912			\|a GBV_ILN_2507
912			\|a GBV_ILN_2522
912			\|a GBV_ILN_2548
912			\|a GBV_ILN_4035
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4046
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4242
912			\|a GBV_ILN_4246
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4251
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4326
912			\|a GBV_ILN_4328
912			\|a GBV_ILN_4333
912			\|a GBV_ILN_4334
912			\|a GBV_ILN_4335
912			\|a GBV_ILN_4336
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4393
912			\|a GBV_ILN_4700
936	b	k	\|a 44.78$jImmunkrankheiten \|q VZ \|0 10640945X \|0 (DE-625)10640945X
951			\|a AR
952			\|d 20 \|j 2023 \|e 3 \|b 04 \|c 04 \|h 160-169

Mapping Community-Engaged Implementation Strategies with Transgender Scientists, Stakeholders, and Trans-Led Community Organizations

Zugang & Verfügbarkeit

Zugehörige Publikationen/Bände